李家超訪京晤高校領導 積極打造「留學香港」品牌 冀更多內地生來港 To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video 【有線新聞】行政長官李家超繼續北京訪問行程，與當地高校領導會面。 李家超下午與清華大學黨委書記邱勇教授會面，歡迎...
李家超訪京晤高校領導 積極打造「留學香港」品牌 冀更多內地生來港 To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video 【有線新聞】行政長官李家超繼續北京訪問行程，與當地高校領導會面。 李家超下午與清華大學黨委書記邱勇教授會面，歡迎清華大學把優勢學科和課程帶到本港規劃中的北都大學城，實現協同發展，又期待清華大學與香港高校繼續深化合作，促進人才培養和科研的優勢互補。李家超又與香港青年交流，勉勵他們把握在北京學習機會，深入了解國情、說好香港故事。李家超晚上與北京高校領導交流時，表示政府積極打造「留學香港」品牌，期待更多內地學生來港就讀。
(RTTNews) - Ameriprise Financial, Inc. (AMP) issued an update on expected impacts to first quarter results and other items. There are 61 trading days in first quarter compared to 64 trading days in fourth quarter of 2025. The company expects that Advice & Wealth Management pretax adjusted operating earnings will be negatively impacted by approximately $6 million as a result of fewer trading days. ...
(RTTNews) - Ameriprise Financial, Inc. (AMP) issued an update on expected impacts to first quarter results and other items. There are 61 trading days in first quarter compared to 64 trading days in fourth quarter of 2025. The company expects that Advice & Wealth Management pretax adjusted operating earnings will be negatively impacted by approximately $6 million as a result of fewer trading days. There are 90 fee days in first quarter compared to 92 fee days in fourth quarter. The company projects pretax adjusted operating earnings will be negatively impacted by approximately $18 million sequentially in Advice & Wealth Management and approximately $10 million sequentially in Asset Management from fewer fee days. The company expects the operating effective tax rate to be in the range of 20%-22% in first quarter and the full year 2026. At last close, Ameriprise Financial shares were trading at $465.68, down 2.03%. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Jag_cz/iStock via Getty Images Thesis MannKind Corporation ( MNKD ) has had a tough couple of weeks. The stock has seen a massive sell-off, with shares trading near their all-time low. Firstly, shareholders got a bit of bad news: United Therapeutics was looking into a new treprostinil formulation. And secondly, 4Q25 earnings swung to a loss. The result is that you can now pick up shares in the low...
Jag_cz/iStock via Getty Images Thesis MannKind Corporation ( MNKD ) has had a tough couple of weeks. The stock has seen a massive sell-off, with shares trading near their all-time low. Firstly, shareholders got a bit of bad news: United Therapeutics was looking into a new treprostinil formulation. And secondly, 4Q25 earnings swung to a loss. The result is that you can now pick up shares in the low $3 range compared to the mid-$5 range when I last reiterated my buy rating on the back of the preliminary earnings release. So if we start with the pretty strategic shift announced by United, this isn’t anything MannKind itself said, but rather United revealed it has plans to launch a new formulation of treprostinil called Tresmi. This is tipped to be delivered via a soft-mist inhaler rather than dry powder. Now, that point is very important and probably what contributed most to the sell-off. You see, MannKind’s largest royalty stream actually comes from Tyvaso DPI, which is a dry-powder inhaled version of treprostinil that MannKind currently manufactures for United. And in the announcement, United’s CEO explicitly framed Tresmi as superior to dry powder. It is claimed to reduce cough, the most common side effect, by up to 90%. United even mentioned that patients would prefer soft mist to dry powder. So, as you can imagine, the market immediately connected the dots in their mind. The narrative is that if United is developing and promoting its own next-generation treprostinil device, it basically threatens the long-term growth and durability of Tyvaso DPI. This is currently the backbone of MannKind’s royalty revenue, and royalty revenue for MannKind is vital to their revenue growth. However, at the same time, it also undercuts the competitive positioning of Liquidia’s Yutrepia, another dry-powder treprostinil product, and even pressures Insmed, which is only developing an inhaled treprostinil formulation. So, in other words, this announcement caused a lot of disruption. The...
Maksim Labkouski/iStock via Getty Images By Lynn Song , Chief Economist, Greater China Manufacturing PMI showed significant divergence China's official manufacturing PMI declined to 49.0 in February, down from 49.3. The data, published by the National Bureau of Statistics, came in weaker than market forecasts for 49.2. The reading below the 50 threshold, which demarcates expansion and contraction,...
Maksim Labkouski/iStock via Getty Images By Lynn Song , Chief Economist, Greater China Manufacturing PMI showed significant divergence China's official manufacturing PMI declined to 49.0 in February, down from 49.3. The data, published by the National Bureau of Statistics, came in weaker than market forecasts for 49.2. The reading below the 50 threshold, which demarcates expansion and contraction, shows manufacturing has now contracted in 10 of the past 11 months. The 49.0 level itself is in line with multiple other months for a 33-month low. The PMI subindices were softer across the board. The production subindex fell to 49.6, a 38-month low, and snapped a 3-month expansion streak. New orders softened notably, down to 48.6, a 32-month low, as new export orders slid to 45.0. Employment also remained at contractionary levels for a 36th consecutive month. Yet the price subindices suggest price recovery, with ex-factory costs up 50.6 and raw material purchase prices at 54.8. In contrast, the RatingDog manufacturing PMI unexpectedly rose to 52.1, up from 50.3. It showed new orders hitting the highest level since 2020. This divergence is likely tied to the sample size of the surveyed companies; this measure is more focused on export-oriented and private enterprises versus the NBS survey. It suggests external demand likely remained resilient for China in the first two months of the year. We will be able to verify this when trade data is released next week. Overall, the mixed bag of manufacturing PMI data suggests a similar trajectory to what we observed in 2025: resilient external demand continuing to drive growth, while domestic demand has been disappointingly soft. Without policy support rollout, domestic demand looks likely to continue to flounder. Key subcategories of the NBS manufacturing index all softened in February Services sector also mirrored the divergence in the manufacturing PMI China's non-manufacturing PMI from the NBS edged up to 49.5, up from 49.4. While...
Michael Carrick has said Manchester United could look to sign a left winger this summer - even though they spent the past three transfer windows under Ruben Amorim getting rid of wide players. Historically, many successful United sides have been built around wingers. George Best, Ryan Giggs, David Beckham and Cristiano Ronaldo are regarded among some of the club's greatest players - while others s...
Michael Carrick has said Manchester United could look to sign a left winger this summer - even though they spent the past three transfer windows under Ruben Amorim getting rid of wide players. Historically, many successful United sides have been built around wingers. George Best, Ryan Giggs, David Beckham and Cristiano Ronaldo are regarded among some of the club's greatest players - while others such as Steve Coppell, Gordon Hill, Willie Morgan and Andrei Kanchelskis also made a significant impact. Although not a winger in the orthodox sense, Busby Babe Eddie Colman was nicknamed 'snake hips' for his ability to change direction at top speed. United began last season with five experienced wide players. Between them, Jadon Sancho, Antony and Amad Diallo cost the club £173m. Marcus Rashford and Alejandro Garnacho both came through the United's youth ranks, although the latter was at Atletico Madrid before moving to Manchester as a 16-year-old in 2020. Sancho is currently on loan at Aston Villa, having spent last season at Chelsea, who paid a £5m clause to send the 25-year-old back to United last summer rather than sign him permanently. His contract is set to expire in the summer, and it seems unlikely United will keep the England international, signed by Ole Gunnar Solskjaer in 2021. Solskjaer intended to play him on the right but the player said his preference was to play on the left. Antony left for Real Betis in a £21.65m deal last September, a couple of days after Garnacho joined Chelsea for £40m. Rashford, who also prefers to play on the left, spent the second half of last season at Villa following a fall-out with Amorim, and then joined Barcelona on loan last summer. Barca have a £26m option to buy Rashford, and talks have started over the possibility of triggering it. However, sources close to the player have indicated no agreement is in place - and given Rashford has two years left on his £325,000-a-week United contract, further negotiation is going to be requi...
Advertisement Recent share performance and business scale Advanced Micro Devices (AMD) has drawn investor attention after a recent pullback, with the stock showing a 3.9% decline over the past day and double digit declines over the past week and month. Despite this weaker recent stretch, the company reports annual revenue of US$34.64b and net income of US$4.27b, with both revenue and profit showin...
Advertisement Recent share performance and business scale Advanced Micro Devices (AMD) has drawn investor attention after a recent pullback, with the stock showing a 3.9% decline over the past day and double digit declines over the past week and month. Despite this weaker recent stretch, the company reports annual revenue of US$34.64b and net income of US$4.27b, with both revenue and profit showing positive annual growth based on the latest figures provided. The recent 1 month share price return of a 19.34% decline and 7 day decline of 10.70% suggest momentum has cooled, although the 1 year total shareholder return of 89.53% still points to a strong longer term payoff for investors who stayed invested. If you are reassessing AMD after this pullback, it may be a useful time to see what else is moving in AI hardware. You can start with our as a curated set of related opportunities. With AMD trading at US$190.95 and sitting at an estimated 31% intrinsic discount, plus a significant gap to the average analyst target, you have to ask: is this a genuine opportunity, or is the market already pricing in future growth? Most Popular Narrative: 36.4% Undervalued At a last close of $190.95 versus a narrative fair value of $300, the most followed AMD storyline presents a much higher long term potential, according to oscargarcia. The 6-Gigawatt (GW) Commitment: Meta has committed to deploying up to 6 gigawatts of AI compute power using AMD Instinct GPUs over the next several years. For context, 1GW is roughly enough to power a large city; in data centre terms, this represents tens of billions of dollars in hardware. Read the complete narrative. Curious how that kind of AI hardware demand is expressed in a single valuation number? The narrative focuses on accelerating revenue, rising margins and richer future earnings power. The full story connects those elements into that $300 figure. Result: Fair Value of $300 (UNDERVALUED) However, this story can break if Nvidia keeps a clear p...
Dexterra Group ( DXT:CA ) declares CAD 0.10/share quarterly dividend , in line with previous. Payable April 15; for shareholders of record March 31; ex-div March 31. See DXT:CA Dividend Scorecard, Yield Chart, & Dividend Growth. More on Dexterra Group Seeking Alpha’s Quant Rating on Dexterra Group Historical earnings data for Dexterra Group Dividend scorecard for Dexterra Group Financial informati...
Dexterra Group ( DXT:CA ) declares CAD 0.10/share quarterly dividend , in line with previous. Payable April 15; for shareholders of record March 31; ex-div March 31. See DXT:CA Dividend Scorecard, Yield Chart, & Dividend Growth. More on Dexterra Group Seeking Alpha’s Quant Rating on Dexterra Group Historical earnings data for Dexterra Group Dividend scorecard for Dexterra Group Financial information for Dexterra Group
The rout in Indian equities following the outbreak of war in the Middle East is the latest hurdle facing Indian companies looking to go public, raising the prospect of a prolonged slowdown in issuance after two record-breaking years. Potential issuers now have to contend with heightened volatility denting investor appetite and clouding visibility on valuations. Indian companies raised $1.5 billion...
The rout in Indian equities following the outbreak of war in the Middle East is the latest hurdle facing Indian companies looking to go public, raising the prospect of a prolonged slowdown in issuance after two record-breaking years. Potential issuers now have to contend with heightened volatility denting investor appetite and clouding visibility on valuations. Indian companies raised $1.5 billion this quarter from initial public offerings, compared with $2.3 billion in the same period last year, according to data compiled by Bloomberg. It’s the latest sign that one of the world’s hottest venues for IPOs is cooling as concerns mount over an economic slowsown, foreign outflows and a weak currency. Local stocks lag Asian peers after their worst January in a decade. Several companies came to the market with downsized deals and new stocks often showed lackluster performance. Clean Max Enviro Solutions Ltd., which debuted on Monday, is trading about 20% below its IPO price. “Although not many issues are planned for March, it is natural that concerns around the war, rising oil prices, the economic impact and inflation will affect market sentiment,” said V. Jayasankar, managing director at Kotak Investment Banking. “Issuers are likely to adopt a wait-and-watch approach until markets show clearer signs of stability.” While only a handful of offerings were scheduled for March, sentiment has turned cautious as investors gauge the impact of the conflict. The benchmark NSE Nifty 50 Index slipped as much as 2.3% on Wednesday, taking its slump this year close to 7%. Even so, deal activity has not come to a halt. SEDEMAC Mechatronics Ltd.’s 13.52 billion-rupee ($147 million) IPO opened on Wednesday, while the National Highways Authority of India ’s infrastructure investment trust is preparing to launch a 60 billion-rupee ($651 million) offering on March 11. Rajputana Stainless Ltd. is set to open a smaller share sale on March 9, and Blackstone-backed Bagmane Prime Office REIT is p...